Covered recipient · General Payments record
DAVID NAZMY ZAKI MIKHAEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$605.44
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.82 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $284.09 | 16 |
| Medtronic, Inc. | $89.95 | 1 |
| PFIZER INC. | $36.20 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.53 | 2 |
| Lilly USA, LLC | $31.21 | 2 |
| Amgen Inc. | $28.85 | 2 |
| EISAI INC. | $19.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.55 | 1 |
| DEXCOM, INC. | $17.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.72 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117328229 | CMS |
| Amgen Inc. | $14.13 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117328231 | CMS |
| Dexcom, Inc. | $17.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295627 | CMS |
| Eisai Inc. | $19.00 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741117 | CMS |
| Lilly USA, LLC | $16.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136159329 | CMS |
| Lilly USA, LLC | $14.45 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136156167 | CMS |
| Medtronic, Inc. | $89.95 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117037429 | CMS |
| Novartis Pharmaceuticals Corporation | $15.18 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087150930 | CMS |
| Novartis Pharmaceuticals Corporation | $16.35 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087150946 | CMS |
| Novo Nordisk Inc | $16.92 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096946266 | CMS |
| Novo Nordisk Inc | $15.82 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097034376 | CMS |
| Novo Nordisk Inc | $16.80 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918984 | CMS |
| Novo Nordisk Inc | $19.19 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096842719 | CMS |
| Novo Nordisk Inc | $18.41 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096869675 | CMS |
| Novo Nordisk Inc | $19.80 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097235391 | CMS |
| Novo Nordisk Inc | $17.47 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096701641 | CMS |
| Novo Nordisk Inc | $19.12 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097208199 | CMS |
| Novo Nordisk Inc | $18.50 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097298457 | CMS |
| Novo Nordisk Inc | $17.19 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097802042 | CMS |
| Novo Nordisk Inc | $16.36 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096580193 | CMS |
| Novo Nordisk Inc | $18.38 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890424 | CMS |
| Novo Nordisk Inc | $13.71 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995633 | CMS |
| Novo Nordisk Inc | $15.89 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096754668 | CMS |
| Novo Nordisk Inc | $22.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097650355 | CMS |
| Novo Nordisk Inc | $17.61 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569828 | CMS |
| PFIZER INC. | $18.34 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132123084 | CMS |
| PFIZER INC. | $17.86 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131198721 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.55 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137635808 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.